Lacosamide and Bleeding disorders - a phase IV clinical study of FDA data

Summary:

Bleeding disorders is reported as a side effect among people who take Lacosamide (lacosamide), especially for people who are male, 20-29 old, also take Perampanel, and have Status epilepticus.

The phase IV clinical study analyzes which people have Bleeding disorders when taking Lacosamide. It is created by eHealthMe based on reports of 16,542 people who have side effects when taking Lacosamide from the FDA, and is updated regularly.

What is Lacosamide?

Lacosamide has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 16,601 Lacosamide users. Check the latest studies of Lacosamide.

What is Bleeding disorders?

Bleeding disorders is found to be associated with 1,196 drugs and 1,648 conditions by eHealthMe. Check the latest studies of Bleeding disorders.

On Jul, 15, 2026

16,542 people reported to have side effects when taking Lacosamide.
Among them, 31 people (0.19%) have Bleeding disorders.

Could Lacosamide cause Bleeding disorders?

Among these 31 people:

What is the gender of people who have Bleeding disorders when taking Lacosamide? *

female: 31.25 %
male: 68.75 %

What is the age of people who have Bleeding disorders when taking Lacosamide? *

What are other drugs people take besides Lacosamide? *

What are other side effects people have besides Bleeding disorders? *

Intestinal Atresia (malformation where there is a narrowing or absence of a portion of the intestine): 16 people, 51.61%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 13 people, 41.94%
Pulmonary Haemorrhage (acute bleeding from the lung): 13 people, 41.94%
Premature Baby: 12 people, 38.71%
Arrhythmias (irregular heartbeat): 10 people, 32.26%
Hypotension (abnormally low blood pressure): 10 people, 32.26%
Pressure Ulcer: 10 people, 32.26%
Infection: 9 people, 29.03%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 29.03%
Hypernatraemia (an abnormally high plasma concentration of sodium ions): 9 people, 29.03%

What are the existing conditions these people have? *

Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 13 people, 41.94%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 8 people, 25.81%
Sedation: 7 people, 22.58%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 6.45%
Complex Partial Seizures (epileptic seizure): 2 people, 6.45%
Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 1 person, 3.23%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 1 person, 3.23%
Hyperglycemia (high blood sugar): 1 person, 3.23%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Lacosamide and have Bleeding disorders?

- Check whether Bleeding disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lacosamide:

Lacosamide (16,601 reports)

Browse all side effects of Lacosamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding disorders:

Bleeding disorders (1,196 drugs)

Browse all the conditions that are associated with Bleeding disorders:

Bleeding disorders (1,648 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lacosamide (the active ingredients of Lacosamide) and Lacosamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.